BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age : A Test Negative Design

© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society..

In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after ≥3 months. A booster improved protection to 77% [53-88].

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Journal of the Pediatric Infectious Diseases Society - 12(2023), 3 vom: 18. Apr., Seite 177-179

Sprache:

Englisch

Beteiligte Personen:

Tartof, Sara Y [VerfasserIn]
Frankland, Timothy B [VerfasserIn]
Puzniak, Laura [VerfasserIn]
Slezak, Jeff M [VerfasserIn]
Hong, Vennis [VerfasserIn]
Takhar, Harpreet [VerfasserIn]
Ogun, Oluwaseye A [VerfasserIn]
Simmons, Sarah [VerfasserIn]
Xie, Fagen [VerfasserIn]
Zamparo, Joann [VerfasserIn]
Ackerson, Bradley K [VerfasserIn]
Jodar, Luis [VerfasserIn]
McLaughlin, John M [VerfasserIn]

Links:

Volltext

Themen:

BNT162 Vaccine
BNT162b2
Booster
COVID-19
Delta
Effectiveness
Journal Article
Kaiser Permanente
Omicron
Pediatric
Real-world
SARS-CoV-2
Test-negative
United States

Anmerkungen:

Date Completed 20.04.2023

Date Revised 21.04.2023

published: Print

Citation Status MEDLINE

doi:

10.1093/jpids/piad005

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352254793